Sera Prognostics Inc. (SERA) NASDAQ

$10.03 0.37 (3.83%)

Market Cap: $313.23M

As of 04/15/24 03:59 PM EDT. Market closed.

(SERA)

Sera Prognostics Inc. (SERA)
NASDAQ

$10.03
0.37 (3.83%)

Market Cap: $313.23M

As of 04/15/24 03:59 PM EDT. Market closed.

Add to Portfolio

sera prognostics is a private biotechnology company developing innovative diagnostic tests designed for the early prediction of preterm birth risk and other pregnancy complications. sera’s tests are designed to help better inform the care of a mother and her unborn child during pregnancy, and potentially lead to improved health. the company has assembled a strong management team and board of ... read more

sera prognostics is a private biotechnology company developing innovative diagnostic tests designed for the early prediction of preterm birth risk and other pregnancy complications. sera’s tests are designed to help better inform the care of a mother and her unborn child during pregnancy, and potentially lead to improved health. the company has assembled a strong management team and board of directors with significant clinical development and women’s healthcare diagnostic experience. the company is supported by a strong group of investors, including the bill & melinda gates foundation, chione, ltd, domain associates, interwest partners, catalyst health ventures, upstart life sciences capital, and osage university partners. the company is working with the bill & melinda gates foundation to translate its discoveries and develop technologies to benefit women and infants in underserved countries worldwide. sera prognostics is located in salt lake city, utah. sera launched its first diagnos read less

COMPANY PROFILE
Sector
Health Care and Social Assistance
Industry
Diagnostic Imaging Centers
URL
Address
.
Sector
Health Care and Social Assistance
Industry
Diagnostic Imaging Centers
Full Time Employees
96
Address
.
PRICE CHART FOR SERA PROGNOSTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$9.74
Previous Close
$9.66
Days Range
$9.41 - $11.15
52 week range
$1.52 - $11.32
Volume
122,520
Avg. Volume (30 days)
287,012
Market Cap
$313.23M
Dividend Yield
-
P/E
(8.64)
Shares Outstanding
32,425,661
Open
$9.74
Previous Close
$9.66
Days Range
$9.41 - $11.15
52 week range
$1.52 - $11.32
Volume
122,520
Avg. Volume (30 days)
287,012
Market Cap
$313.23M
Dividend Yield
-
P/E
(8.64)
Shares Outstanding
32,425,661
FINANCIAL STATEMENTS FOR SERA PROGNOSTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR SERA PROGNOSTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Boniface John J.Chief Scientific OfficerMar 28, 2024 Option Exercise$0.9124,47422,271164,245Mar 28, 2024, 05:56 PM
Boniface John J.Chief Scientific OfficerMar 27, 2024 Option Exercise$0.9148,90944,507188,680Mar 28, 2024, 05:56 PM
Boniface John J.Chief Scientific OfficerMar 28, 2024 Sale$9.0424,474221,245139,771Mar 28, 2024, 05:56 PM
Boniface John J.Chief Scientific OfficerMar 27, 2024 Sale$9.6252,662506,608139,771Mar 28, 2024, 05:56 PM
Lindgardt ZhenyaChief Executive OfficerMar 26, 2024 Sale$9.3738,899364,484908,104Mar 26, 2024, 08:00 PM
Aerts AustinChief Financial OfficerMar 26, 2024 Sale$9.378,09275,822322,488Mar 26, 2024, 08:00 PM
Boniface John J.Chief Scientific OfficerMar 26, 2024 Sale$9.5521,438204,733143,524Mar 26, 2024, 05:38 PM
Boniface John J.Chief Scientific OfficerMar 25, 2024 Sale$9.1022,163201,683164,962Mar 26, 2024, 04:20 PM
Boniface John J.Chief Scientific OfficerMar 06, 2024 Sale$9.021,66415,009187,125Mar 07, 2024, 04:16 PM
Aerts AustinChief Financial OfficerMar 06, 2024 Sale$9.024444,005330,580Mar 07, 2024, 04:16 PM
Kearney PaulChief Data OfficerMar 06, 2024 Sale$9.021,0289,273159,038Mar 07, 2024, 04:16 PM
Harrison Robert GardnerChief Information OfficerMar 06, 2024 Sale$9.022,13819,285145,697Mar 07, 2024, 04:15 PM
Jackson BenjaminGeneral CounselMar 06, 2024 Sale$9.021,85616,741150,179Mar 07, 2024, 04:15 PM
Jackson BenjaminGeneral CounselFeb 06, 2024 Sale$8.035,66545,490152,035Feb 07, 2024, 04:57 PM
Boniface John J.Chief Scientific OfficerFeb 06, 2024 Sale$8.035,66545,490188,789Feb 07, 2024, 04:57 PM
Kearney PaulChief Data OfficerFeb 06, 2024 Sale$8.034,98440,022160,066Feb 07, 2024, 04:56 PM
Harrison Robert GardnerChief Information OfficerFeb 06, 2024 Sale$8.035,66545,490147,835Feb 07, 2024, 04:56 PM
Lindgardt ZhenyaChief Executive OfficerFeb 06, 2024 Sale$8.0327,997224,816947,003Feb 07, 2024, 04:56 PM
Aerts AustinChief Financial OfficerFeb 06, 2024 Sale$8.039,78678,582331,024Feb 07, 2024, 04:56 PM
Jackson BenjaminGeneral CounselDec 07, 2023 Sale$5.2210,00052,200157,700Dec 07, 2023, 09:35 PM
Boniface John J.Chief Scientific OfficerDec 07, 2023 Sale$4.805,00024,000194,454Dec 07, 2023, 09:35 PM
Harrison Robert GardnerChief Information OfficerJun 05, 2023 Sale$3.235,00016,15028,500Jun 06, 2023, 04:07 PM
Kearney PaulChief Data OfficerApr 06, 2023 Option Exercise$0.7524,05018,03840,050Apr 07, 2023, 04:14 PM
Boniface John J.Chief Scientific OfficerSep 08, 2022 Option Exercise$0.7384461647,354Sep 09, 2022, 04:17 PM
Boniface John J.Chief Scientific OfficerJul 27, 2022 Option Exercise$0.731,00073047,510Jul 27, 2022, 06:54 PM
Boniface John J.Chief Scientific OfficerJul 26, 2022 Sale$2.152,7255,85946,510Jul 27, 2022, 06:54 PM
Boniface John J.Chief Scientific OfficerJul 27, 2022 Sale$2.221,0002,22046,510Jul 27, 2022, 06:54 PM
Boniface John J.Chief Scientific OfficerJul 19, 2022 Sale$1.862,7255,06949,235Jul 19, 2022, 07:38 PM
Boniface John J.Chief Scientific OfficerJul 12, 2022 Sale$1.842,7255,01451,960Jul 13, 2022, 04:06 PM
Boniface John J.Chief Scientific OfficerJul 05, 2022 Sale$1.632,7254,44254,685Jul 05, 2022, 06:37 PM
Boniface John J.Chief Scientific OfficerJun 29, 2022 Option Exercise$0.731,00073058,410Jun 29, 2022, 07:00 PM
Boniface John J.Chief Scientific OfficerJun 28, 2022 Sale$1.892,7255,15057,410Jun 29, 2022, 07:00 PM
Boniface John J.Chief Scientific OfficerJun 29, 2022 Sale$1.721,0001,72057,410Jun 29, 2022, 07:00 PM
Boniface John J.Chief Scientific OfficerJun 21, 2022 Sale$1.312,7253,57060,135Jun 21, 2022, 05:34 PM
Jackson BenjaminGeneral CounselJun 14, 2022 Buy$1.208,0009,6008,000Jun 16, 2022, 04:19 PM
Boniface John J.Chief Scientific OfficerJun 14, 2022 Sale$1.212,7253,29762,860Jun 16, 2022, 04:19 PM
Boniface John J.Chief Scientific OfficerJun 07, 2022 Sale$1.302,7253,54265,585Jun 07, 2022, 05:30 PM
Boniface John J.Chief Scientific OfficerJun 01, 2022 Option Exercise$0.731,00073069,310Jun 01, 2022, 05:41 PM
Boniface John J.Chief Scientific OfficerMay 31, 2022 Sale$1.452,7253,95168,310Jun 01, 2022, 05:41 PM
Boniface John J.Chief Scientific OfficerJun 01, 2022 Sale$1.361,0001,36068,310Jun 01, 2022, 05:41 PM
Boniface John J.Chief Scientific OfficerMay 24, 2022 Sale$1.542,7254,19671,035May 24, 2022, 06:16 PM
Boniface John J.Chief Scientific OfficerMay 17, 2022 Sale$1.552,7254,22473,760May 17, 2022, 06:41 PM
Boniface John J.Chief Scientific OfficerMay 10, 2022 Sale$1.972,7255,36876,485May 10, 2022, 06:47 PM
Boniface John J.Chief Scientific OfficerMay 04, 2022 Option Exercise$0.731,00073080,210May 04, 2022, 06:15 PM
Boniface John J.Chief Scientific OfficerMay 04, 2022 Sale$2.171,0002,17079,210May 04, 2022, 06:15 PM
Boniface John J.Chief Scientific OfficerMay 03, 2022 Sale$2.172,7255,91379,210May 03, 2022, 05:43 PM
Boniface John J.Chief Scientific OfficerApr 26, 2022 Sale$2.172,7255,91381,935Apr 26, 2022, 06:28 PM
Boniface John J.Chief Scientific OfficerApr 19, 2022 Sale$2.082,7255,66884,660Apr 20, 2022, 04:36 PM
Boniface John J.Chief Scientific OfficerApr 12, 2022 Sale$2.662,7257,24987,385Apr 13, 2022, 04:26 PM
Boniface John J.Chief Scientific OfficerApr 06, 2022 Option Exercise$0.731,00073091,110Apr 07, 2022, 04:09 PM
Boniface John J.Chief Scientific OfficerApr 05, 2022 Sale$3.352,7259,12990,110Apr 07, 2022, 04:09 PM
Boniface John J.Chief Scientific OfficerApr 06, 2022 Sale$3.021,0003,02090,110Apr 07, 2022, 04:09 PM
Boniface John J.Chief Scientific OfficerMar 29, 2022 Sale$3.732,72510,16492,835Mar 30, 2022, 04:07 PM
Boniface John J.Chief Scientific OfficerMar 22, 2022 Sale$3.682,72510,02895,560Mar 23, 2022, 04:11 PM
Boniface John J.Chief Scientific OfficerMar 14, 2022 Sale$3.942,72510,73798,285Mar 15, 2022, 05:58 PM
Boniface John J.Chief Scientific OfficerMar 11, 2022 Option Exercise$0.7375,99855,479101,010Mar 14, 2022, 04:16 PM
Boniface John J.Chief Scientific OfficerDec 06, 2021 Option Exercise$0.7325,01218,25925,012Dec 06, 2021, 09:15 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Boniface John J.Chief Scientific Officer03/28/202422,271
Boniface John J.Chief Scientific Officer03/27/202444,507
Boniface John J.Chief Scientific Officer03/28/2024221,245
Boniface John J.Chief Scientific Officer03/27/2024506,608
Lindgardt ZhenyaChief Executive Officer03/26/2024364,484
Aerts AustinChief Financial Officer03/26/202475,822
Boniface John J.Chief Scientific Officer03/26/2024204,733
Boniface John J.Chief Scientific Officer03/25/2024201,683
Boniface John J.Chief Scientific Officer03/06/202415,009
Aerts AustinChief Financial Officer03/06/20244,005
Kearney PaulChief Data Officer03/06/20249,273
Harrison Robert GardnerChief Information Officer03/06/202419,285
Jackson BenjaminGeneral Counsel03/06/202416,741
Jackson BenjaminGeneral Counsel02/06/202445,490
Boniface John J.Chief Scientific Officer02/06/202445,490
Kearney PaulChief Data Officer02/06/202440,022
Harrison Robert GardnerChief Information Officer02/06/202445,490
Lindgardt ZhenyaChief Executive Officer02/06/2024224,816
Aerts AustinChief Financial Officer02/06/202478,582
Jackson BenjaminGeneral Counsel12/07/202352,200
Boniface John J.Chief Scientific Officer12/07/202324,000
Harrison Robert GardnerChief Information Officer06/05/202316,150
Kearney PaulChief Data Officer04/06/202318,038
Boniface John J.Chief Scientific Officer09/08/2022616
Boniface John J.Chief Scientific Officer07/27/2022730
Boniface John J.Chief Scientific Officer07/26/20225,859
Boniface John J.Chief Scientific Officer07/27/20222,220
Boniface John J.Chief Scientific Officer07/19/20225,069
Boniface John J.Chief Scientific Officer07/12/20225,014
Boniface John J.Chief Scientific Officer07/05/20224,442
Boniface John J.Chief Scientific Officer06/29/2022730
Boniface John J.Chief Scientific Officer06/28/20225,150
Boniface John J.Chief Scientific Officer06/29/20221,720
Boniface John J.Chief Scientific Officer06/21/20223,570
Jackson BenjaminGeneral Counsel06/14/20229,600
Boniface John J.Chief Scientific Officer06/14/20223,297
Boniface John J.Chief Scientific Officer06/07/20223,542
Boniface John J.Chief Scientific Officer06/01/2022730
Boniface John J.Chief Scientific Officer05/31/20223,951
Boniface John J.Chief Scientific Officer06/01/20221,360
Boniface John J.Chief Scientific Officer05/24/20224,196
Boniface John J.Chief Scientific Officer05/17/20224,224
Boniface John J.Chief Scientific Officer05/10/20225,368
Boniface John J.Chief Scientific Officer05/04/2022730
Boniface John J.Chief Scientific Officer05/04/20222,170
Boniface John J.Chief Scientific Officer05/03/20225,913
Boniface John J.Chief Scientific Officer04/26/20225,913
Boniface John J.Chief Scientific Officer04/19/20225,668
Boniface John J.Chief Scientific Officer04/12/20227,249
Boniface John J.Chief Scientific Officer04/06/2022730
Boniface John J.Chief Scientific Officer04/05/20229,129
Boniface John J.Chief Scientific Officer04/06/20223,020
Boniface John J.Chief Scientific Officer03/29/202210,164
Boniface John J.Chief Scientific Officer03/22/202210,028
Boniface John J.Chief Scientific Officer03/14/202210,737
Boniface John J.Chief Scientific Officer03/11/202255,479
Boniface John J.Chief Scientific Officer12/06/202118,259
Load More Insider Transactions
FUNDS WITH A POSITION IN SERA PROGNOSTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BAKER BROS. ADVISORS LP5,434,3990.37%258.63%Other
VIVO CAPITAL, LLC1,650,4400.81%-11.08%Other
GEODE CAPITAL MANAGEMENT, LLC202,5950.00013%13.63%Other
BLACKROCK INC.87,9580.00001%52.63%Other
CHANGE IN SHARES OUTSTANDING FOR SERA PROGNOSTICS INC
STOCK BUYBACKS FOR SERA PROGNOSTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.42%
1Q
12/31/2023
06/30/2023
1.09%
2Q
12/31/2023
03/31/2023
1.28%
3Q
12/31/2023
12/31/2022
1.28%
4Q
12/31/2023
09/30/2022
1.32%
5Q
12/31/2023
06/30/2022
1.52%
6Q
12/31/2023
03/31/2022
2.00%
7Q
12/31/2023
09/30/2021
25.24%
9Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.42%
1Q
06/30/2023
1.09%
2Q
03/31/2023
1.28%
3Q
12/31/2022
1.28%
4Q
09/30/2022
1.32%
5Q
06/30/2022
1.52%
6Q
03/31/2022
2.00%
7Q
09/30/2021
25.24%
9Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR SERA PROGNOSTICS INC
LOADING...